Hello!
I'm Leslie Dewhurst and after a career in Technology, Transformation and Turn Around, I founded Health-AI mid 2020 after I was diagnosed with kidney failure and underwent an altruistic kidney transplant.
Health-AI uses AI, to humanise and improve post-transplant healthcare and help reduce its spiralling cost.
You can read my story here
​
But the real story is still unfolding along with our new Intelligent Assistants.
Read more below about Health-AI's remarkable growth and product development:
Health-AI: Our Story so far
We're a story of determined progress in adverse times. TCAS, our first AI-based Intelligent Assistant launched just as the Covid crisis reached its height. Undeterred, we continued with our one year patient-led study leading to TrackMyTac, our first Windows based App allowing patients at home or on the move to monitor their own key drug data by using a tablet or lap top. Click here to see the results of our one year patient-based study.
​
Fast forward three years and we're now an award winning Digital Healthtech with a market of over $3 Billion, annually. Our Intelligent Assistants are in use on three continents and in patient based studies, enabling patients to benefit from advances in digital Dose Tech and AI-based coaching.
​
Post Covid, we've continued our Development and Testing work and announced TrackMyTac, allowing doctors and patients world wide to access our first globally available Intelligent Assistant.
​
To help us move forward our ESG plans, we'll be adopting Zero Based Environmental Budgeting (ZBeeB) to help us manage and where we can, reduce our net environmental emissions
​
To support our international growth, we've invested in our Intellectual Property including Trade Marks for our product names and patents for the Predictive-AI used in our Intelligent Assistants.
​​
​
​
​
​
​
​
​
​
​
Health-AI: Our product evolution
2021 - TCAS (Tacrolimus Chaser and Stabiliser)
Used by: Kidney patients, post transplant; physicians, nephrologists. Provides: Basic Dose Tech; Tacrolimus level forecast; coaching.
2023 - TrackMyTac® (TMT)
Used by: Kidney & liver patients, post transplant; physicians, nephrologists. Provides: Advanced Dose Tech; Tac level predictive AI; advanced coaching.
2024 - Kia Ora (TMT on Mobile)
2025 - DoseBuddy (Allows TMT patients to mentor each-other)
And look-out for:
2025 - DoseBuddy+ (Enables friends and family to mentor a TMT patient)
2025 - New TMT Extensions
Contact
Contact us for a TrackMyTac demonstration or just to share about AI in HealthCare, or,
Just connect!